Ovarian Cancer: Moving to a Personalized Treatment Approach
59:45
Clinicians Connect: Conversations w/ FDA's CMO on reducing cases of congenital syphilis & syphilis
2:47:58
FDA FY2025 Small Business Fair
50:02
Cannabis Products and the Potential Impact on Patients
1:57:53
Clinical Pharmacology Considerations for Novel Therapeutic Modalities
4:38:30
FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)
1:57:16
M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms - Implementing the Final Guidance
4:07:45
FDA Clinical Investigator Training Course (CITC) 2024 (Day 3 of 3)
7:46:16